OPGN logo

OpGen, Inc. Stock Price

OTCPK:OPGN Community·US$140.9m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

OPGN Share Price Performance

US$14.95
14.33 (2,313.72%)
US$14.95
14.33 (2,313.72%)
Price US$14.95

OPGN Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with acceptable track record.

2 Risks
1 Reward

OpGen, Inc. Key Details

US$9.0m

Revenue

-US$488.0

Cost of Revenue

US$9.0m

Gross Profit

US$2.3m

Other Expenses

US$6.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
0.67
100.01%
74.56%
0%
View Full Analysis

About OPGN

Founded
2001
Employees
1
CEO
Christian-Laurent Bonte
WebsiteView website
www.opgen.com

OpGen, Inc., a precision medicine company, develops and commercializes molecular microbiology solutions for life threatening infectious diseases in the United States and internationally. The company’s products include Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel test products, and SARS CoV-2 test kits. It also provides laboratory services; collaboration services, including funded software arrangements; and license arrangements services. In addition, the company offers listing sponsorship and consultancy services. OpGen, Inc. was incorporated in 2001 and is based in Clarksburg, Maryland.

Recent OPGN News & Updates

Recent updates

No updates